Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azacitidine Compared to Conventional Chemotherapy in Consolidation of Elderly Patients (65 Years or Older) With AML in First Complete Remission

NCT01794169 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT01794169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01794169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azacitidine Compared to Conventional Chemotherapy in Consolidation of Elderly Patients (65 Years or Older) With AML in First Complete Remission
Lead sponsor
Karolinska University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2013
Completion date
March 31, 2018
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia